Article Versions Notes

Martini S, Figini M, Croce A, Frigerio B, Pennati M, Gianni AM, De Marco C, Daidone MG, Argueta C, Landesman Y, et al. Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody. Cells. 2020; 9(10):2231. https://doi.org/10.3390/cells9102231

Martini, Silvia, Mariangela Figini, Aurora Croce, Barbara Frigerio, Marzia Pennati, Alessandro Massimo Gianni, Cinzia De Marco, Maria Grazia Daidone, Christian Argueta, Yosef Landesman, and et al. 2020. "Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody" Cells 9, no. 10: 2231. https://doi.org/10.3390/cells9102231

Martini, S., Figini, M., Croce, A., Frigerio, B., Pennati, M., Gianni, A. M., De Marco, C., Daidone, M. G., Argueta, C., Landesman, Y., Zaffaroni, N., & Satta, A. (2020). Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody. Cells, 9(10), 2231. https://doi.org/10.3390/cells9102231